Disease ID | Disease name | Source of annotation with PLCB1 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
PS308350 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE | OMIM | link to OMIM | 37 | KCNT1, EEF1A2, SZT2, ALG13, ST3GAL3, WWOX, ITPA, SIK1, SCN1A, ARHGEF9, GNAO1, TBC1D24, DNM1, SLC35A2, GRIN2B, SLC13A5, SLC25A22, HCN1, KCNB1, STXBP1, SCN9A, PNKP, KCNQ2, SPTAN1, KCNA2, SCN2A, PLCB1, AARS, PCDH19, CDKL5, GABRA1, SLC12A5, DOCK7, ARX, SCN8A, NECAP1, PIGA |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Platelet activation | hsa04611 | 5.66 |
cGMP-PKG signaling pathway | hsa04022 | 5.32 |
Calcium signaling pathway | hsa04020 | 5.22 |
Long-term potentiation | hsa04720 | 6.64 |
Retrograde endocannabinoid signaling | hsa04723 | 6.03 |
Cholinergic synapse | hsa04725 | 5.88 |
Glutamatergic synapse | hsa04724 | 5.84 |
Serotonergic synapse | hsa04726 | 5.84 |
Dopaminergic synapse | hsa04728 | 5.69 |
Chemokine signaling pathway | hsa04062 | 5.19 |
Oxytocin signaling pathway | hsa04921 | 5.4 |
Inositol phosphate metabolism | hsa00562 | 6.72 |
Endocrine and other factor-regulated calcium reabsorption | hsa04961 | 7.12 |
Circadian entrainment | hsa04713 | 6.11 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
African trypanosomiasis | hsa05143 | 7.68 |
Amoebiasis | hsa05146 | 5.82 |
Wnt signaling pathway | hsa04310 | 5.49 |
Vascular smooth muscle contraction | hsa04270 | 5.74 |
Gap junction | hsa04540 | 6.24 |
Pathways in cancer | hsa05200 | 3.98 |
GnRH signaling pathway | hsa04912 | 6.18 |
Phosphatidylinositol signaling system | hsa04070 | 6.38 |
Rap1 signaling pathway | hsa04015 | 4.97 |
Insulin secretion | hsa04911 | 6.18 |
Melanogenesis | hsa04916 | 5.97 |
Estrogen signaling pathway | hsa04915 | 6.11 |
Thyroid hormone synthesis | hsa04918 | 6.56 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 |
Long-term depression | hsa04730 | 6.74 |
Salivary secretion | hsa04970 | 6.23 |
Gastric acid secretion | hsa04971 | 6.48 |
Pancreatic secretion | hsa04972 | 6.07 |
Metabolic pathways | hsa01100 | 2.49 |
Inflammatory mediator regulation of TRP channels | hsa04750 | 6.07 |
Huntington's disease | hsa05016 | 5.17 |
Alzheimer's disease | hsa05010 | 5.34 |
Adrenergic signaling in cardiomyocytes | hsa04261 | 5.44 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.34 |
Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.98 |
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.98 |
Metabolism | R-HSA-1430728 | 2.34 |
G-protein beta:gamma signalling | R-HSA-397795 | 7.31 |
Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
Ca2+ pathway | R-HSA-4086398 | 7.1 |
Neuronal System | R-HSA-112316 | 4.82 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | R-HSA-112314 | 5.85 |
Transmission across Chemical Synapses | R-HSA-112315 | 5.28 |
GPCR downstream signaling | R-HSA-388396 | 3.07 |
beta-catenin independent WNT signaling | R-HSA-3858494 | 5.83 |
Integration of energy metabolism | R-HSA-163685 | 6.24 |
Inositol phosphate metabolism | R-HSA-1483249 | 7.52 |
Signaling by Wnt | R-HSA-195721 | 4.79 |
Regulation of insulin secretion | R-HSA-422356 | 6.66 |
PLC beta mediated events | R-HSA-112043 | 7.52 |
G-protein mediated events | R-HSA-112040 | 7.49 |
Activation of Kainate Receptors upon glutamate binding | R-HSA-451326 | 8.08 |
Opioid Signalling | R-HSA-111885 | 6.64 |
Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.66 |
G alpha (q) signalling events | R-HSA-416476 | 5.42 |
Presynaptic function of Kainate receptors | R-HSA-500657 | 8.59 |
G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.66 |
Signal Transduction | R-HSA-162582 | 1.78 |
GO term | GO ID | GO IC |
---|---|---|
enzyme binding | GO:0019899 | 2.27 |
phosphoric ester hydrolase activity | GO:0042578 | 3.82 |
binding | GO:0005488 | 0.18 |
signal transducer activity | GO:0004871 | 2.28 |
molecular function regulator | GO:0098772 | 2.51 |
cation binding | GO:0043169 | 1.4 |
phosphoric diester hydrolase activity | GO:0008081 | 5.23 |
phospholipid binding | GO:0005543 | 3.91 |
phosphatidylinositol-4,5-bisphosphate binding | GO:0005546 | 5.81 |
ion binding | GO:0043167 | 1.36 |
phosphatidylinositol bisphosphate binding | GO:1902936 | 5.79 |
calcium ion binding | GO:0005509 | 3.17 |
lamin binding | GO:0005521 | 6.91 |
identical protein binding | GO:0042802 | 2.63 |
protein homodimerization activity | GO:0042803 | 3.16 |
hydrolase activity | GO:0016787 | 1.9 |
enzyme regulator activity | GO:0030234 | 2.85 |
GTPase activator activity | GO:0005096 | 4.11 |
lipid binding | GO:0008289 | 3.26 |
hydrolase activity, acting on ester bonds | GO:0016788 | 3.1 |
GTPase regulator activity | GO:0030695 | 4.01 |
phosphatidylinositol phosphate binding | GO:1901981 | 5.05 |
nucleoside-triphosphatase regulator activity | GO:0060589 | 3.92 |
phospholipase activity | GO:0004620 | 5.16 |
phosphatidylinositol phospholipase C activity | GO:0004435 | 6.41 |
metal ion binding | GO:0046872 | 1.41 |
catalytic activity | GO:0003824 | 1.05 |
phosphatidylinositol binding | GO:0035091 | 4.47 |
phospholipase C activity | GO:0004629 | 6.3 |
calmodulin binding | GO:0005516 | 4.55 |
protein binding | GO:0005515 | 0.46 |
protein dimerization activity | GO:0046983 | 2.72 |
lipase activity | GO:0016298 | 4.96 |
enzyme activator activity | GO:0008047 | 3.56 |